Table 4.
Drug Name | Key Finding | Type of data Computational/Experimental/Observational |
Reference |
---|---|---|---|
Gonadorelin | Binds to SARS-CoV-2 RBD | Computational (Docking and MD simulation) | [22] |
Fondaparinux | Binds to SARS-CoV-2 RBD (KD = 10.3 μmol/L) | Experimental (Surface Plasmon Resonance) | [52] |
Atorvastatin | Linked to a lower risk of COVID19 mortality | Observational (Retrospective study) | [53] |
FAD | Binds to SARS-CoV2 RBD | Computational (Molecular Docking) | [17] |
Hyaluronic acid | Induces conformational change in RBD | Experimental (Circular Dichroism) | [56] |
Pralatrexate | Binds to RBD | Computational (Molecular Docking) | [55] |